The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 7, 2012, Pages 609-614

  Strom, Charles M ^a   Bonilla Guererro, Ruben ^a   Zhang, Ke ^a   Doody, Kevin J ^b   Tourgeman, David ^c   Alvero, Ruben ^e   Cedars, Marcelle I ^d   Crossley, Beryl ^d   Pandian, Raj ^a,d   Sharma, Rajesh ^a   Neidich, Julie ^a   Salazar, Denise ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b Center for Assisted Reproduction   (United States)

^c HRC Fertility   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biochemical pregnancy; IVF ET; Pregnancy detection

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLASTOCYST; CONTROLLED STUDY; ECHOGRAPHY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL SAC; GLYCOSYLATION; HEART BEAT; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINE LEVEL;

ADULT; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GLYCOSYLATION; HUMANS; PREGNANCY; PREGNANCY RATE; PREGNANCY TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84864940774     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9774-2     Document Type: Article

References (23)

1. http://www.fertilitystories.com/pregnant.htm, accessed 10/27/2011.
2. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and Peptide structure of the ?- and ?-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine. 1997;7:15-32.
3. Valmu L, Alfthan H, Hotakainen K, Birken S, Stenman UH. Sitespecific glycan analysis of human chorionic gonadotropin {beta}- subunit from malignancies and pregnancy by liquid chromatography - electrospray mass spectrometry. Glycobiology. 2006;16:1207-18.
4. Cole LA. Hyperglycosylated hCG. Placenta. 2007;28:977-86.
5. O'Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn. 1998;18:1232-40.
6. Davies S, Byrn F, Cole LA. Testing for early pregnancy viability and complications. Clinics Lab Med. 2003;23:257-64.
7. Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens N. Hyperglycosylated hCG (Invasive Trophoblast Antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem. 2003;36:647-55.
8. Sutton-Riley JM, Khanlian SA, Byrn FW, Cole LA. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem. 2006;39:682-7.
9. Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, CohenM, Kelly A, Schlatterer J, O'Connor JF. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002;172:497-506.
10. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol. 2006;102:144-9.
11. Cole LA, Sutton JM, Higgins TN, Cembrowski GS. Betweenmethod variation in human chorionic gonadotropin test results. Clin Chem. 2004;50:874-82.
12. Kovalevskaya G, Kakuma T, Schlatterer J, O'Connor JF. Hyperglycosylate HCG expression in pregnancy: cellular origin and clinical applications. Mol Cell Endo. 2007;260-262:237-43.
13. Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud MC, Legul F, Muller D, Evain-Brion D, Fournier T. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95:E240-4.
14. Cole LA, Khanlian SA, Riley JM, Butler SA. Hyperglycosylated hCG (hCG-H) in gestational implantation, and in choriocarcinoma and testicular germ cell malignancy tumorigenesis. J Reprod Med. 2006;51:919-29.
15. Handschuh K, Guibourdenche J, Tsatsari V, Guesnon M, Laurendeau I, Evain-Brion D, Fournier T. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is downregulated by peroxisome proliferator-activated receptor-a. Endocrinol. 2007;148:5011-9.
16. http://cran.r-project.org/
17. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. New Engl J Med. 2001;345:1400-8.
18. Bahado-Singh RO, Oz U, Shahabi S, et al. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Am J Obstet Gynecol. 2000;183:1114-8.
19. Bahado-Singh RO, Oz UA, Shahabi S, et al. Urine hyperglycosylated hCG plus ultrasound biometry for detection of Down syndrome in the second trimester in a high-risk population. Obstet Gynecol. 2000;95:889-94.
20. Cole LA. ITA (hyperglycosylated hCG) a powerful serum and urine screening method in maternal Down syndrome detection: Update 2002. Down Syndr News. 2002;9:25.
21. Palomaki GE, Knight GJ, Neveux LM, et al. Maternal serum invasive trophoblast antigen and first-trimester down syndrome screening. Clin Chem. 2005;51:1499-504.
22. Palomaki GE, Neveux LM, Haddow JE, et al. HyperglycosylatedhCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy. Prenat Diagn. 2007;27:808-13.
23. Weinans MJN, Sancken U, Pandian R, et al. Invasive trophoblast antigen (hyperglycosylated human chorionic gonadotropin) as a first-trimester serum marker for Down syndrome. Clin Chem. 2005;51:1276-9.